Lundqvist, A., V. van Hoef, X. Zhang, E. Wennerberg, J. Lorent, K. Witt, L. M. Sanz, et al. 2016. “31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016.” Journal for Immunotherapy of Cancer 4 (Suppl 1): 1-106. doi:10.1186/s40425-016-0172-7. http://dx.doi.org/10.1186/s40425-016-0172-7.
Powderly, J., G. Cote, K. Flaherty, R. Z. Szmulewitz, A. Ribas, J. Weber, D. Loo, et al. 2015. “Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3.” Journal for Immunotherapy of Cancer 3 (Suppl 2): O8. doi:10.1186/2051-1426-3-S2-O8. http://dx.doi.org/10.1186/2051-1426-3-S2-O8.